Principle Investigators
- TRAC Co-PI, Clinical Science Core Director
Professor of Medicine at Weill Cornell Medicine
Director of the Weill Cornell Center for Global Health
Dr. Fitzgerald has conducted research on tuberculosis in Haiti and Tanzania for over 25 years. His tuberculosis research includes clinical trials to optimize diagnosis and treatment of both latent and active TB and translational studies of Mtb persistence. He leads 3 NIH Fogarty International Center research training programs for US and international physician scientists. He brings expertise in TB trials, translational research, international collaboration, research training and program management.
- TRAC Co-PI
Professor of Medicine and Microbiology and Immunology at Weill Cornell Medicine
Dr. Rhee has pioneered the development and application of metabolomic technologies that enable systems-level biochemical studies of Mtb. He is the PI of a recently funded program project P01 on transmission aerobiology of M. tuberculosis. Dr. Rhee also has significant administrative leadership experience as a founding signatory of the Bill & Melinda Gates Foundation TB Drug Accelerator and Director of three Tri-Institutional research-training programs.
Core Directors
- TRAC Developmental Core Co-Director
Professor and Head of the St. Giles Laboratory of Human Genetics of Infectious Diseases at The Rockefeller University
He is a Howard Hughes Medical Institute international scholar who studies the host genetic and immunologic basis of infectious diseases. He is a member of the National Academy of Sciences and the National Academy of Medicine.
- TRAC Basic Science Core Director
Professor of Microbiology and Immunology at Weill Cornell Medicine
Dr. Ehrt investigates the molecular mechanisms that enable M. tuberculosis to establish and maintain chronic infections and resist host defenses. She is the PI of the Tri-Institutional TBRU (AI162568, 2021-2026) and a T32 training program in microbiology (AI134622).
- TRAC Basic Science Core Co-Director
The Alfred P. Sloan Chair in the Immunology Program at Memorial Sloan Kettering
Professor at Weill Cornell Medicine
Dr. Glickman is Co-PI of the Tri-Institutional TBRU with Dr. Ehrt. His laboratory uses a multidisciplinary approach that includes microbial genetics, biochemistry, molecular biology, lipid biochemistry, and immunology in the study of M. tuberculosis. He will lead the Basic Science Core with Dr. Ehrt and serve as the primary liaison between the TRAC and Memorial Sloan Kettering.
- TRAC Administrative Core, Program Manager
Senior Research Associate
Dr. Haba has been working on clinical TB trial coordination and research. She also has been coordinating training for international clinician-scientists which is funded by NIH.
- TRAC Developmental Core Director
The R.A. Rees Pritchett Professor
Chair of the Department of Microbiology and Immunology at Weill Cornell Medicine
Dr. Nathan was involved in the discovery of the roles of IFNγ, TGF-β, and TNFα in macrophages. He is the founder of the Tri-I MD-PhD Program and chair of the Tri-I Therapeutics Discovery Institute planning committee. Dr. Nathan is a member of the National Academy of Sciences and the National Academy of Medicine. He is committed to the mentorship of rising junior faculties.
- TRAC Clinical Science Core Co-Director
Director of GHESKIO in Haiti
Professor of Medicine at Weill Cornell Medicine
Dr. Pape has been a leader in HIV and TB research for 30 years. He is PI of the NIAID Clinical Trials Unit in Haiti conducting trials in HIV and TB. Dr. Pape was the recipient of the 2010 Lifetime Achievement Award from the Union against TB and Lung Diseases. He has received numerous honors, including the Legion of Honor from the President of France (2002) and election to the United States National Academy of Medicine (2004).
Basic Science Experts
- Weill Cornell Medicine
- Mycobacterial Genetics, Drug Discovery & Development
Clinical Science Experts
Technical Experts
- Memorial Sloan Kettering
- Mycobacterial Genetics, Recombinant DNA Technology Genetics
- Weill Cornell Medicine
- Genetic Screening Technologies (TnSeq & CRISPRi)
- Weill Cornell Medicine
- “OMICS” Technologies: Metabolomics/Lipidomics
Administrative Expert
- Weill Cornell Medicine
- Budget Management